These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 309344)

  • 21. Aromatic L-amino acid decarboxylase enzyme activity in deficient patients and heterozygotes.
    Verbeek MM; Geurtz PB; Willemsen MA; Wevers RA
    Mol Genet Metab; 2007 Apr; 90(4):363-9. PubMed ID: 17240182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of L-dopa on plasma renin activity with and without inhibition of extracerebral dopa decarboxylase in dogs.
    Blair ML; Reid IA; Ganong WF
    J Pharmacol Exp Ther; 1977 Jul; 202(1):209-15. PubMed ID: 874815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence of endogenous inhibitor of aromatic L-amino acid decarboxylase in monkey serum.
    Rahman MK; Togari A; Kojima K; Takahashi K; Nagatsu T
    Mol Cell Biochem; 1984 Aug; 63(1):53-8. PubMed ID: 6333583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interaction of L-DOPA and pyridoxine (a review of the literature)].
    Uspenskiĭ AE
    Farmakol Toksikol; 1977; 40(6):722-33. PubMed ID: 340258
    [No Abstract]   [Full Text] [Related]  

  • 25. [ACTION OF DIFFERENT INHIBITORS OF L-DOPA-5-HTP DECARBOXYLASE ON AN INDUCED HYPERTHERMIA OF CENTRAL ORIGIN].
    HELBECQUE C; JUILLARD AM; HEROLD M; CAHN J
    C R Seances Soc Biol Fil; 1963 Oct; 157():996-9. PubMed ID: 14092126
    [No Abstract]   [Full Text] [Related]  

  • 26. On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic L-amino acid decarboxylase-serotonin-dopamine-norepinephrine).
    Christenson JG; Dairman W; Udenfriend S
    Proc Natl Acad Sci U S A; 1972 Feb; 69(2):343-7. PubMed ID: 4536745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irreversible inhibition of aromatic-L-amino acid decarboxylase by alpha-difluoromethyl-DOPA and metabolism of the inhibitor.
    Ribéreau-Gayon G; Palfreyman MG; Zraïka M; Wagner J; Jung MJ
    Biochem Pharmacol; 1980 Sep; 29(18):2465-9. PubMed ID: 7426053
    [No Abstract]   [Full Text] [Related]  

  • 28. [Influence of vitamin B6 on L-aromatic amino acid decarboxylase in the organs of spontaneously hypertensive rats (SHR)].
    Yoshimine N; Kazuya F
    Nihon Ronen Igakkai Zasshi; 1974 Jan; 11(1):28-32. PubMed ID: 4475240
    [No Abstract]   [Full Text] [Related]  

  • 29. [5-HYDROXYTRYPTOPHAN DOPA DECARBOXYLASE IN NERVOUS AND CARDIAC TISSUES IN THE MOLLUSC HELIX POMATIA. INTERACTION OF SUBSTRATES IN VITRO].
    CARDOT J
    C R Hebd Seances Acad Sci; 1964 Jul; 259():902-4. PubMed ID: 14190531
    [No Abstract]   [Full Text] [Related]  

  • 30. Demonstration of aromatic l-amino acid decarboxylase activity in human brain with l-dopa and l-5-hydroxytryptophan as substrates by high-performance liquid chromatography with electrochemical detection.
    Rahman MK; Nagatsu T
    Neurochem Int; 1982; 4(1):1-6. PubMed ID: 20487843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation in brain and liver DOPA/5HTP decarboxylase activity after L-DOPA administration with or without pyridoxine in cats.
    Roberge AG
    J Neurochem; 1977 Mar; 28(3):479-85. PubMed ID: 300789
    [No Abstract]   [Full Text] [Related]  

  • 32. Block of cerebral actions of L-dopa with methyl receptor substances.
    Cotzias GC; Tang L; Ginos JZ; Nicholson AR; Papavasiliou PS
    Nature; 1971 Jun; 231(5304):533-5. PubMed ID: 4934569
    [No Abstract]   [Full Text] [Related]  

  • 33. Homologs of dopa, alpha-methyldopa, and dopamine as potential cardiovascular drugs.
    Winn M; Rasmussen R; Minard F; Kyncl J; Plotnikoff N
    J Med Chem; 1975 Apr; 18(4):434-7. PubMed ID: 1079053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time and dose influences on the behavioral effects of L-DOPA and 5-hydroxytryptophan after inhibition of extracerebral decarboxylase.
    Gronan RJ
    Pharmacol Biochem Behav; 1975; 3(2):161-6. PubMed ID: 1079949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of catechol structure in the inhibitory effects of D-isomers of amino acids on the decarboxylation of L-5-hydroxytryptophan.
    Shikimi T; Inagaki C; Takaori S
    Experientia; 1978 Sep; 34(9):1188-9. PubMed ID: 309827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of l-dopa and alpha-methyl-dopa on C cell secretion in the thyroid gland.
    Zabel M; Warchoł JB
    Acta Med Pol; 1977; 18(4):387-90. PubMed ID: 24984
    [No Abstract]   [Full Text] [Related]  

  • 37. Direct and decarboxylation-dependent effects of neurotransmitter precursors on firing of isolated monoaminergic neurons.
    Dyakonova VE; Chistopolsky IA; Dyakonova TL; Vorontsov DD; Sakharov DA
    J Comp Physiol A Neuroethol Sens Neural Behav Physiol; 2009 Jun; 195(6):515-27. PubMed ID: 19274466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of N-(DL-seryl)N'-(2,3,4-trihydroxybenzyl)-hydrazine with L-dopa decarboxylase from pig kidney.
    Borri-Voltattorni C; Minelli A; Borri P
    Experientia; 1977 Feb; 33(2):158-60. PubMed ID: 300332
    [No Abstract]   [Full Text] [Related]  

  • 39. alpha-difluoromethyl DOPA, a new enzyme-activated irreversible inhibitor of aromatic L-amino acid decarboxylase.
    Palfreyman MG; Danzin C; Bey P; Jung MJ; Ribereau-Gayon G; Aubry M; Vevert JP; Sjoerdsma A
    J Neurochem; 1978 Oct; 31(4):927-32. PubMed ID: 308998
    [No Abstract]   [Full Text] [Related]  

  • 40. L- -methyl- -hydrazino- -(3,4-dihydroxyphenyl)propionic acid: relative lack of antidecarboxylase activity in adrenals.
    Horita A; Nair X; Hamilton AE
    Science; 1972 May; 176(4037):931-2. PubMed ID: 4537521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.